                         SEQUENCE LISTING

<110>  ICHILOV TECH LTD.
 
<120>  A METHOD FOR DETERMINING SUITABILITY OF A SUBJECT TO ANTI-TNF 
       ΑLPHA THERAPY

<130>  ICH-P-006-PCT

<150>  US 63/212,678
<151>  2021-06-20

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  1
tgtcactgct actgctgctg                                                   20


<210>  2
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  2
gtgaggtgga tcggttgtag                                                   20


<210>  3
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  3
atggggaagg tgaaggtcg                                                    19


<210>  4
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  4
ggggtcattg atggcaacaa ta                                                22


<210>  5
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  5
acctcattgg tgtcactgct actg                                              24


<210>  6
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  6
tcctcagaat ttgggcatcc t                                                 21


